1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61EC6A463C9D02C9985257D47006B5728
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/1EC6A463C9D02C9985257D47006B5728!OpenDocument
18
19OpenDocument
203.235.140.84
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Market Research, Analytics and Forecasting Analytics

Document Excerpt: Big Data in Pharma: Governance and Data Capabilities Across Medical, Commercial & HEOR Segments

DB Image

Excerpt in Cart

ID: MD-432


Features:

12 Info Graphics

24 Data Graphics

300+ Metrics

3 Narratives


Pages/Slides: 4


Published: Pre-2017


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5328 "Big Data in Pharma: Governance and Data Capabilities Across Medical, Commercial & HEOR Segments."


Industries Profiled:
Pharmaceutical; Health Care; Biotech; Chemical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Merck; Merck Serono; Novartis; Boehringer Ingelheim; Genentech; Teva Pharmaceutical Industries Ltd; Pfizer; Baxter Healthcare; GlaxoSmithKline ; Bayer; Gilead Sciences; Janssen; Lundbeck; Sanofi; Esteve; Daiichi Sankyo; Purdue Pharma; AstraZeneca

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.